Showing results (11-20 of 105) with videos related to
Sort By:
Pageof 11
European Urology Open Science|July 19, 2024
Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early DetectionJonathan Maurer, Philippe J Eugster, Kiana Collins, et al.Drug Testing and Analysis|May 11, 2018
Sensitive quantification of the somatostatin analog AP102 in plasma by ultra-high pressure liquid chromatography-tandem mass spectrometry and application to a pharmacokinetic study in ratsPhilippe J Eugster, Christina N Boyle, Sylvain Prod'hom, et al.Clinical Chemistry|January 11, 2022
Multiplexed Assay to Quantify the PP-Fold Family of Peptides in Human Plasma Using Microflow Liquid Chromatography-Tandem Mass SpectrometryGemma Reverter-Branchat, Philippe J Eugster, Christina Kuenzli, et al.Analytical Chemistry|December 3, 2019
Quantification of Neuropeptide Y and Four of Its Metabolites in Human Plasma by Micro-UHPLC-MS/MSCéline Vocat, Marielle Dunand, Scott A Hubers, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|August 13, 2022
Quantification of serotonin and eight of its metabolites in plasma of healthy volunteers by mass spectrometryPhilippe J Eugster, Marielle Dunand, Baptiste Grund, et al.Journal of Translational Medicine|September 7, 2023
CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumorsJoana Grand-Guillaume, Rosalba Mansi, Raghuvir H Gaonkar, et al.Endocrine|August 20, 2017
Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in ratsErika Tarasco, Petra Seebeck, Svende Pfundstein, et al.Journal of the Endocrine Society|September 19, 2019
Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS InhibitionJessica R Wilson, Scott Jafarian Kerman, Scott A Hubers, et al.Frontiers in Endocrinology|December 19, 2022
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertensionAnnick Mühlethaler-Mottet, Silvia Uccella, Deborah Marchiori, et al.Best Practice & Research. Clinical Endocrinology & Metabolism|October 8, 2013
Determination of catecholamines in plasma and urineEric Grouzmann, Faiza LaminePageof 11